Amarin Corp Plc (AMRN)

[ziploc_1]

Denner's proposal for countries with public health care systems was particularly interesting IMO.

QUOTE...(to various countries) "For an annual licensing fee, at a fraction of what Vascepa will save you in CVD cost, we will supply Vaskepa to your country."

I assume Amarin will profit from the licensing fee...Then Amarin can make individual prescriptions of Vaskepa very inexpensive...Then each country can decide for themselves how available they want Vaskepa to be for their patient population.